Han Biomedical (ROCO:6999) Retained Earnings : NT$27.6 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Han Biomedical Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Han Biomedical's retained earnings for the quarter that ended in Dec. 2024 was NT$27.6 Mil.

Han Biomedical's quarterly retained earnings declined from Dec. 2023 (NT$22.7 Mil) to Jun. 2024 (NT$13.7 Mil) but then increased from Jun. 2024 (NT$13.7 Mil) to Dec. 2024 (NT$27.6 Mil).

Han Biomedical's annual retained earnings increased from Dec. 2022 (NT$18.7 Mil) to Dec. 2023 (NT$22.7 Mil) and increased from Dec. 2023 (NT$22.7 Mil) to Dec. 2024 (NT$27.6 Mil).

Han Biomedical Retained Earnings Historical Data

The historical data trend for Han Biomedical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Han Biomedical Retained Earnings Chart

Han Biomedical Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Retained Earnings

12.14

18.74

22.73

27.60

Han Biomedical Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Retained Earnings	Get a 7-Day Free Trial			18.74	-	22.73	13.74	27.60

Han Biomedical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Han Biomedical (ROCO:6999) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Han Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Han Biomedical Inc (ROCO:6999) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN

Website

https://www.hanbiomedical.com

Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.

Han Biomedical Headlines

No Headlines